← Leaderboards
Lianping Ti
University Of British Columbia
$910,446
Attributed
$910,446
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $494.2K · FY2021–23$500K$375K$250K$125K$0
'21
'22
'23
Funding mix
By agency
NIH$910,446 · 1
By mechanism
R01$910,446 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of British Columbia
Same institution · by research overlap
- Evan Wood$11,404,700
- Gregory Evan Miller$10,106,946
- Danya Fast$286,184
Others in their field
Other Emerging Leaders on “Drug Evaluation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,805,377
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Yunda Huang · Fred Hutchinson Cancer Center$54,459,089
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Research focus
Drug EvaluationAddictionAnalogAdoptedAmericanBehaviorBehavioralBehavior ChangeBehavior TherapyBackCanadaCaringCause Of DeathCenters For Disease Control And Prevention (U.S.)Cessation Of LifeCharacteristicsCocaineCostDancingDecision MakingBritish ColumbiaDemographicsDrug CompoundingDrug Market
Grant awards (2)
Evaluation of Drug Checking as a Novel Intervention to Address the Opioid Overdose Crisis Attributable to Fentanyl and its Analogues$494,190
R01 · FY2023 · DA · contact PI
Evaluation of Drug Checking as a Novel Intervention to Address the Opioid Overdose Crisis Attributable to Fentanyl and its Analogues$416,256
R01 · FY2021 · DA · contact PI